![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 27, 20361-20367, July 7, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Microbiology and Cell Biology, Indian
Institute of Science, Bangalore 560 012, India
Received for publication, February 15, 2000, and in revised form, March 15, 2000
Formylation of the initiator tRNA is essential
for normal growth of Escherichia coli. The
initiator tRNA containing the U35A36 mutation (CUA anticodon) initiates
from UAG codon. However, an additional mutation at position 72 (72A Organisms have evolved with two distinct species of methionyl
tRNAs. Of these, the initiator recognizes the initiation codons (AUG,
GUG, AUU, UUG, etc.), and the elongator decodes the subsequent AUG
codons in a mRNA (1). Both species of the tRNA are aminoacylated by
the same methionyl-tRNA synthetase. In eubacteria, the initiators (Met-tRNAfMet) are then further modified by
formyltransferase to generate formylmethionyl-tRNA (fMet-tRNAfMet), which interacts with IF2 to participate at
the step of initiation (2-4). On the other hand, the elongators
(Met-tRNAMet) bind to EFTu to participate in elongation
cycles. The major structural features that distinguish the initiators
from elongators are located within the acceptor and the anticodon stems
(5-7). A striking feature of the eubacterial initiator tRNAs is the
presence of a mismatch at the 1-72 positions, which constitutes an
important element for their recognition by formyltransferase (8-11).
The mismatch also prevents the binding of the initiators to EF-Tu and
renders the fMet-tRNAfMet resistant to peptidyl-tRNA
hydrolase, PTH1 (12), an
enzyme which hydrolyzes N-blocked aminoacyl and the peptidyl tRNAs to
facilitate tRNA recycling (13, 14).
The initiator tRNA containing CAU to CUA anticodon change,
tRNAfMet (U35A36), is aminoacylated with glutamine (15) and
initiates with formyl-glutamine utilizing UAG as an initiation codon in Escherichia coli (16). However, the tRNAfMet
(U35A36) was rendered nonfunctional in initiation when coupled with an
A to G mutation at position 72 (G72/U35A36). The G72 mutation replaced
the CxA mismatch at the top of the acceptor stem with a strong C-G base
pair. The G72/U35A36 tRNA could be aminoacylated with glutamine but
failed to initiate because it is an extremely poor substrate for
formyltransferase (8, 17).
In this report, we show that a spontaneous intragenic mutation (C Strains and Plasmids--
These are summarized in Table
I (16, 18-22). The new constructs were
generated by using standard recombinant DNA methodology (23).
tRNA Mutants--
All tRNA mutants used in this study were
derived from tRNA2fMet (19)
and are shown in Fig. 1B.
Isolation of the Intragenic Suppressor--
During the course of
isolating multicopy suppressors for G72/U35A36 tRNA by using the
protocol described previously (22), we serendipitously isolated a
chloramphenicol-resistant clone, which did not contain a genomic
insert. The DNA sequence analysis revealed a single nucleotide change
(C Enzyme Assays--
Cell-free extracts were prepared and assayed
for Northern Blot Analysis--
Total tRNA from various
transformants was isolated under acidic conditions, separated on 6.5%
acid urea gels at 4 °C, and electroblotted onto a Nytran membrane
(26). The 5'-32P end-labeled oligodeoxyribonucleotides used
as probes for different blots were complementary to positions 29-47 of
tRNA2fMet (U35A36) and 2-44
of tRNATyr. Conditions used for hybridization of the blots
have been described (26). The 19-mer oligomer probe is complementary to
the anticodon region to the U35A36 tRNAs, and it possesses two
mismatches in the middle when compared with the wild type tRNA
sequence. Thus the signals on the Northern blots correspond to the
initiator tRNA mutants and not to the endogenous host initiator tRNA
(fMet). For detection of tRNA2fMet
or its derivatives with the wild type anticodon (CAU), an oligomer complementary to positions 40-56 of the
tRNA2fMet was used. This oligomer
contains a single mismatch in middle when compared with the
tRNA1fMet. Further to avoid signals
from the host initiator tRNA, we have used E. coli B105 as
host, which contains only the genes corresponding to
tRNA1fMet.
The formylated tRNAs were treated either with 100 mM
Tris-HCl (pH 9.0) or 100 mM CuSO4 to generate
deacylated and formylated markers, respectively. The CuSO4
deacylates the aminoacyl-tRNAfMet but not the
formylaminoacyl-tRNAfMet, whereas the alkali treatment
deacylates both (27, 28).
In Vitro Aminoacylation--
Glutaminyl tRNA synthetase was
purified as before (29). Initiator tRNAs were overproduced in E. coli B105 from respective genes cloned on moderate copy plasmid
pBR322. Total tRNA from 400-ml log phase cultures were prepared by
phenol chloroform extraction method described before (30). The mutant
tRNAs were purified further from native polyacrylamide gels (30) and
used in aminoacylation reactions. All the initiator tRNAs used in this
study are derived from the tRNA2fMet
variant, not present in the E. coli B105 host. The native
gel electrophoresis system affords a clear separation between the tRNA1fMet and
tRNA2fMet in the fastest moving region
of the gel occupied with no other tRNAs (19). Thus the tRNA
preparations are not only free from other tRNAs but also devoid of the
host initiator tRNA background. The pure tRNAs were quantified by
absorbance at 260 nm. The 32P body-labeled tRNAs, used to
spike the cold tRNA preparations to follow the aminoacylation were also
purified as above except that the cells harvested from 4-ml log phase
cultures were grown further in low phosphate-containing culture medium
supplemented with 0.5 mCi of [32P]orthophosphate for
1 h (30).
Aminoacylation reactions (25) were carried out in a 30-µl volume with
60,000 cpm of labeled tRNA, 500 pmols (12.5 µg) of unlabeled pure
tRNA at 37 °C for various times. The GlnRS concentrations for
different tRNAs were decided from range finding experiments. Aliquots
(5 µl) were drawn at different time points and fractionated on acid
urea gels (26). The bands corresponding to aminoacylated and deacylated
tRNA were visualized by autoradiography, and the corresponding gel
pieces were quantified using a scintillation counter. The percent
aminoacylation was calculated as [{counts in the aminoacylated
band/(counts in the aminoacylated band + counts in the remaining
deacylated band)} × 100] and was used to determine pmols of
product formed/µg of GlnRS, which in turn was plotted as a function
of time. Initial velocities of aminoacylation were determined from the
slopes of the straight lines corresponding to the initial phase of the reaction.
Isolation of the U1G72/U35A36 Intragenic Suppressor--
The
binary plasmid system used to carry out in vivo initiation
assays is shown in Fig. 1A.
The ACYC origin of replication based plasmid, pACQS, harbors
glutaminyl-tRNA synthetase gene. The ColE1-based plasmid,
pCATam1metYCUA, carries the mutant
initiator tRNA (U35A36 or G72/U35A36) and the CAT reporter,
CATam1, genes (16). The mutants of initiator tRNA with
U35A36 (CAU to CUA anticodon change) are aminoacylated with glutamine.
The U35A36 tRNA initiates from the UAG initiation codon of the reporter
mRNA and confers chloramphenicol resistance. However, the
G72/U35A36 tRNA fails to initiate because it is defective in
formylation.
During the course of characterizing suppressors for the G72/U35A36 tRNA
(see "Experimental Procedures") we isolated a
chloramphenicol-resistant clone, which contained a single nucleotide
change (C Initiation Activity of U1G72/U35A36 tRNA--
The cell-free
extracts prepared from the transformants harboring the U35A36 or
U1G72/U35A36 tRNA were assayed for the relative CAT activity
(normalized to In Vivo Status of U1G72/U35A36 tRNA--
Total tRNAs were isolated
under acidic conditions and analyzed on acid urea gels to determine
in vivo status of the G72/U35A36 and U1G72/U35A36 tRNAs. As
reported (26), the G72/U35A36 tRNA was distributed between deacylated
and aminoacylated forms (Fig. 2,
lane 3), whereas the U1G72/U35A36 tRNA accumulated in
deacylated and formylated forms (Fig. 2, lanes 1 and
2). Presence of the formylated form of U1G72/U35A36 tRNA
explained its activity in initiation.
However, considering that the U1G72/U35A36 tRNA lacked a Watson-Crick
base pair at the 1-72 positions and that the analysis was carried out
under GlnRS overproduction, it was intriguing (31) to note that a
substantial amount of this tRNA accumulated in the deacylated form
(Fig. 2, lanes 1 and 2). The presence of a
predominant single band corresponding to Tyr-tRNATyr showed
that the tRNAs were not deacylated during preparation. Therefore, the
accumulation of the deacylated form could either be because of the
inefficient aminoacylation or because the fGln-tRNAfMet
(U1G72/U35A36) is a substrate for PTH.
In Vitro Aminoacylation Kinetics of tRNA Mutants by
GlnRS--
The efficiencies of aminoacylation as determined
from the initial velocities are presented in Table
II. Consistent with earlier observations,
the relative efficiency of aminoacylation of G72/U35A36 tRNA was ~6%
with respect to the U35A36 tRNA. Rate of aminoacylation of U1G72/U35A36
tRNA was substantially better than that of the G72/U35A36 tRNA and only
~2-fold worse than that the U35A36 tRNA. Interestingly, the
aminoacylation efficiency of the U1G72/U35A36 tRNA was as good as the
U1/U35A36 tRNA containing the U1-A72 base pair similar to the one found
in the tRNAGln (31).
Hydrolysis of fGln-tRNA (U1G72/U35A36) by Peptidyl-tRNA
Hydrolase--
In vivo status of the U1G72/U35A36 tRNA was
analyzed in two additional strains of E. coli, CP78 and
AA7852, in the presence or absence of GlnRS overproduction (Fig.
3). The two strains are isogenic except
that AA7852 carries a temperature-sensitive mutation in pth
(permissive at 30 °C and nonpermissive at 37 °C). The U1/U35A36 tRNA, with a Watson-Crick base pair at positions 1-72 (U1-A72), is a
good substrate for PTH and was used as a control.
In the CP78 strain, expectedly, the U1/U35A36 tRNA accumulated only in
deacylated form irrespective of the levels of GlnRS or the growth
temperature (Fig. 3, lanes 1-4). As before (Fig. 2), the
U1G72/U35A36 tRNA was found distributed between the formylated and
deacylated forms (Fig. 3, lanes 5-8). However, in the
absence of GlnRS overproduction, the tRNA accumulated somewhat more in the deacylated form (compare lanes 5 with 6, or
7 with 8) irrespective of the temperature at
which the cells were grown (compare lanes 5 and 6 with 7 and 8, respectively).
On the other hand, in the AA7852 strain, at the permissive temperature
(30 °C) the U1/U35A36 was found to be distributed between the
deacylated and formylated forms, and as expected its accumulation in
the formylated form increased substantially when GlnRS was overproduced
(compare lanes 9 and 10). Although at the
nonpermissive temperature (37 °C) both the deacylated and the
formylated forms were seen, all of the deacylated form was converted
into the formylated form in the presence of GlnRS overproduction
(compare lanes 11 and 12). This observation
suggested that although PTH is a major reason for the U1/U35A36 tRNA to
accumulate into the deacylated form, its poor aminoacylation by GlnRS
also contributed to it. Similar to U1/U35A36 tRNA, U1G72/U35A36 tRNA
was distributed between the formylated and the deacylated forms at the
permissive temperature in the AA7852 strain. However, it was seen to
accumulate entirely in the formylated state at the nonpermissive
temperature, irrespective of the state of GlnRS overproduction. These
observations suggested that U1G72/U35A36 tRNA is a substrate for PTH
albeit not as good as the U1/U35A36 tRNA, which contains a Watson-Crick
base pair at the 1-72 positions.
To confirm our observations further, we cloned the pth gene
into pCATam1 harboring the U1G72/U35A36 or the U35A36 tRNA
genes (pCATam1.metYU1G72/CUApth
and
pCATam1.metYCUApth,
respectively) and analyzed the tRNAs on acid urea gels (Fig.
4). Upon PTH overproduction, the
U1G72/U35A36 tRNA accumulated into aminoacylated and deacylated forms
(Fig. 4A, lane 2). A band corresponding to its
formylated form was not detectable showing that in vivo,
U1G72/U35A36 is a substrate for PTH. However, to our surprise, the
U35A36 tRNA with a mismatch at the 1-72 positions accumulated entirely
into the deacylated form upon PTH overproduction (Fig. 4B,
compare lanes 3 and 4 or 5 and
6). The marker, lanes 1 and 2, correspond to the deacylated and the formylated forms of the U35A36
tRNA, respectively. Complete lack of accumulation of aminoacylated form of U35A36 tRNA (as opposed to U1G72/U35A36 tRNA) is most likely because
this tRNA is a very good substrate for formyltransferase, and as soon
as it is formylated, it is hydrolyzed by PTH or utilized in initiation
through IF2 (as shown below). These results suggested that the mismatch
at the 1-72 positions, which is considered a hallmark for the
resistance of the initiator tRNA toward PTH, is not sufficient in
preventing its hydrolysis by PTH. Thus the presence of a minor band
corresponding to the deacylated form of the U35A36 tRNA in the absence
of GlnRS overproduction (Fig. 4B, lane 3) could
be because of a combined effect of lower rates of aminoacylation and
the partial hydrolysis of the formylated tRNA by PTH.
Role of the Amino Acid Attached to the Initiator tRNA in Its
Recognition by Peptidyl-tRNA Hydrolase--
In nature, initiation
occurs with fMet. For efficient initiation, it is desirable that the
fMet-tRNAfMet is prevented from its wasteful hydrolysis
because of PTH. Our observation, that the CxA mismatch at 1-72
positions of the tRNAfMet is not sufficient in conferring
resistance to PTH, was made with a tRNA-carrying fGln. Could it be that
the amino acid attached to the tRNA also plays a role in preventing its
hydrolysis by PTH? Therefore, we examined the steady state levels of
tRNAfMet (U1G72) and tRNAfMet (with CAU
anticodon, hence aminoacylated with Met) in the presence or absence of
PTH and/or MetRS overproduction in E. coli B105, which lacks
endogenous tRNA2fMet (19). Because all
our tRNA mutants are derivatives of
tRNA2fMet, it was possible to detect the
tRNA2fMet free from the host background
of tRNA1fMet by the use of an oligomeric
probe spanning the variable loop. This region harbors adenosine at
position 46 in tRNA2fMet as opposed to
7-methyl guanosine in tRNA1fMet (32).
Both the tRNAfMet and the corresponding
tRNAfMet(U1G72) were completely formylated with or without
overproduction of MetRS (Fig. 5,
lanes 1, 3, 5, and 7). And, as would be relevant from the physiological considerations, the fMet-tRNAfMet
remained formylated even when PTH was overproduced (lanes 2 and 4). On the other hand, overproduction of PTH resulted in
the appearance of the aminoacylated and deacylated forms of
tRNAfMet (U1G72) (lane 6), suggesting that the
tRNAfMet (U1G72) is a substrate for PTH even when fMet was
attached to it. Expectedly, when MetRS was overproduced, the deacylated
form was converted into the aminoacylated form (lane 8). The
fact that even upon PTH overproduction a considerable level of tRNA
(U1G72) is detected in the formylated form and suggested that the
initiator tRNAs are more resistant to PTH when they carry fMet than
when they carry fGln. Nevertheless, these observations show that both the amino acid and the 1-72 positions are important in recognition or
rejection of the initiator tRNAs by PTH.
PTH and IF2 Compete for the fGln-tRNAfMet
Species--
As the formylated forms of the U1G72/U35A36 and U35A36
were hydrolyzed by PTH, it was of interest to investigate the in
vivo initiation activities of these tRNAs in the presence and the
absence of PTH overproduction. Further, as both the PTH and IF2 bind to the formylated forms of tRNA, the effect of IF2 overproduction was also
studied (Table III). Upon PTH
overproduction, the initiation activity of the U1G72/U35A36 tRNA
decreased by ~15-fold (3.8% from 56.14%). Consistent with this
drastic decrease in initiation, steady state accumulation of the
formylated form of the U1G72/U35A36 tRNA was also not seen (Fig.
4A, lane 2). On the other hand, although the
U35A36 tRNA also did not show any steady state accumulation of
formylated form (Fig. 4B, lane 4 and
6), in this case there was only a 2-fold decrease (47.7%
from 100%) in initiation upon PTH overproduction. A most likely
explanation for this apparent disparity is that the two tRNAs have
different affinities toward IF2. This difference in the affinity toward
IF2 also provides a rationale for nearly half as efficient initiation
with U1G72/U35A36 tRNA (with respect to U35A36 tRNA) (Table III) even
though considerable levels of this tRNA accumulated in the formylated
form in the absence of PTH overproduction (Fig. 2).
As shown in Table III, overproduction of IF2 led to an increase in
initiation (4-5-fold) by both the tRNAs (100 to 511 for U35A36 and
56.14 to 230.8 for U1G72/U35A36 tRNAs). Interestingly, in the presence
of IF2 overproduction, the initiation activities of the tRNAs without
or with PTH overproduction were comparable (511 versus
494.71 and 230.8 versus 238.8 for U35A36 and U1G72/U35A36 tRNAs, respectively), and the decrease in initiation activity because
of PTH overproduction was completely annulled by simultaneous overproduction of IF2. Consistent with this observation, overproduction of IF2 facilitated accumulation of U35A36 tRNA in formylated form (compare Fig. 4B, lanes 5 and 6, with
Fig. 6, lanes 1 and
2). Similarly, overproduction of IF2 resulted in the
presence of a single band corresponding to the formylated form of
U1G72/U35A36 tRNA (compare Fig. 4A, lane 1, to
Fig. 6, lane 3). However, as the U1G72/U35A36 tRNA is a good
substrate for PTH, the absence of the formylated form in the presence
of PTH overproduction, even when IF2 was simultaneously overproduced
(Fig. 6, lane 4), was not unexpected. It is very likely that
as soon as the tRNA is formylated it is hydrolyzed by PTH and the
protection conferred by IF2 binding is not detectable by Northern
analysis of the total tRNA, which detects the steady state levels of
the different forms.
Effect of PTH Overproduction on the Path Adopted by
tRNAfMet--
The CxA mismatch at positions 1-72 of the
tRNAfMet and the formylation of the initiator tRNAs prevent
their binding to EFTu and therefore their participation in elongation.
Creation of a base pair at the 1-72 position allows the initiator
tRNAs to bind to EFTu and participate at the elongation step (25, 26).
Recently, using tRNAfMet (U35A36) it was shown that upon
EFTu overproduction, it participated in elongation even though it
contains the CxA mismatch at 1-72 positions (3).
E. coli CA274 has an internal amber mutation in the
lacZ gene. This amber codon can be suppressed by tRNAs with
the CUA anticodon, and the Our studies with a formylation-defective initiator tRNA
(G72/U35A36) resulted in isolation of an intragenic suppressor
(U1G72/U35A36). The presence of the U1G72/U35A36 tRNA in formylated
form (Fig. 2) explains its activity in initiation and highlights the
significance of formylation in protein synthesis in E. coli.
More importantly, the biochemical and the in vivo analyses
involving U1G72/U35A36 tRNA have allowed us to elaborate on the
distribution of the initiator tRNAs with various proteins that interact
with them. We show that, in vivo, the tRNAs with a wobble
base pair (U1-G72) at the top of acceptor stem are substrates for PTH.
Also, we discovered that the mismatch (C1xA72) alone at these positions
of the initiator tRNA, which was thus far considered to be a hallmark
for its resistance toward hydrolysis by PTH, is not sufficient in
preventing the wasteful hydrolysis of the formylated tRNA because of
PTH. The role of the amino acid attached to the tRNA becomes evident
from the observation that initiator tRNA (with C1xA72 mismatch) is completely resistant to hydrolysis by PTH when charged with fMet but
not when it was charged with fGln (Figs. 4 and 5).
The crystal structure of PTH shows that its active/binding site
accommodates the C-terminal end
(Lys191-Ala-Gln193) of the neighboring PTH
molecule via several electrostatic interactions (34). Our observations
that (i) fGln-tRNAfMet (CUA) is a substrate for PTH and the
fMet-tRNAfMet is not and (ii) the fGln-tRNAfMet
(U1G72/U35A36) is a better substrate than the fMet-tRNAfMet
(U1G72) for PTH (Figs. 4 and 5) do suggest that the side chains of the
amino acids influence the contacts between the enzyme and the substrate
and thereby affect the esterase activity of the enzyme. In addition, an
earlier observation that AcMet-tRNAfMet (U1G72) was not a
substrate for PTH (35) may be extended to suggest that the nature of
modification of the Overproduction of IF2 led to an ~5-fold increase in the efficiency of
initiation with fGln (Table III). Importantly, when IF2 was
overproduced simultaneously with the PTH, it rescued the decrease in
initiation activity that resulted upon the overproduction of PTH alone.
The protective effect of IF2 on the formylated tRNAs against their
hydrolysis by PTH was also clearly discernible from the steady state
accumulation of the different forms of tRNA in the cell (compare Figs.
4 and 6).
Our data suggest that after its aminoacylation the initiator tRNA is
distributed between the formyltransferase and EFTu. The majority of the
aminoacyl-tRNAfMet bound to formyltransferase is formylated
and committed for the purpose of initiation (Fig.
7, bold arrows). Evidently,
when this equilibrium is favored for binding of the initiator tRNAs to
EFTu by its overproduction (3), their participation in elongation is
detectable and significant. Thus, a small population of the initiator
tRNA must bind to EFTu (Fig. 7, thin arrows) even when EFTu
is not overproduced. Understandably, the mutants of initiators, which
are poor substrates for formyltransferase, would partition more with
EFTu. This interpretation is corroborated by an earlier study wherein
the mutant initiator tRNAs such as U1/U3A70/U35A36, G3C70/U35A36,
G72/U35A36, G72G73/U35A36, and U1/U2A70/U35A36 etc., which are poor
substrates for the formyltransferase, function as good elongators
(17).
In the present study, we observed that overproduction of PTH led to
substantial increase in elongation activity of U35A36 and U1G72/U35A36
tRNAs. Because the EFTu binds to the aminoacyl tRNA and the PTH binds
to the formylated form of the tRNA, PTH overproduction is unlikely to
have any direct effect in facilitating better binding of the aminoacyl
tRNA to EFTu. A simple interpretation of this observation is that every
time an aminoacyl tRNA is released from the aminoacyl-tRNA synthetase,
it is subjected to competition for its binding between the
formyltransferase and EFTu. Although the wild type initiator binds
predominantly to formyltransferase, some finite fraction of the
aminoacyl-tRNA that escapes binding to formyltransferase must partition
with EFTu and which in turn participates in elongation. The fact that
fGln-tRNAfMet (CUA) is a substrate for PTH, suggests that
the overproduction of PTH greatly enhances the turnover of the
formylated tRNA (Fig. 7). The cumulative effect of the small finite
fractions of the aminoacylated tRNA that bind to EFTu thus results in a
significant level of elongation by the initiator tRNA. Because both the
IF2 and PTH bind to the formylated tRNA, it is reasonable to assume that the two proteins compete with one another for the
formylaminoacyl-tRNA available in the cell. Thus, our observation that
overproduction of IF2 results in steady state accumulation of the
formylated tRNA is a consequence of the protection conferred by IF2
against hydrolysis by PTH. However, an implication of this finding is that overproduction of IF2 decreases the levels of the formylated form
of the tRNA in the cell that now remains available to bind to PTH for
its hydrolysis. Consistent with our hypothesis that it is the increased
turn over of formylated tRNA that is responsible for its participation
in elongation, IF2 overproduction abates the elongation activity of the
initiator tRNA that accrued as a result of PTH overproduction.
In conclusion, our studies with PTH and/or IF2 overproduction show that
a critical balance of various proteins that interact with the initiator
tRNA is crucial to ensure its appropriate use in the cell. Further,
these studies provide an important clue to understand the dual function
of a single tRNAMet in initiation and elongation in the
mitochondria of various organisms (36).
We thank Prof. U. L. RajBhandary for
critically reviewing this manuscript as well as for providing us with
many of the plasmid constructs used in this study. The recombinant
plasmids containing PTH and IF2 genes used to generate various plasmid
constructs were originally provided by Drs. G. Guarneros and J. Hershey, respectively.
*
This work was supported by the financial assistance from
Department of Science and Technology, Government of India, New Delhi.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by the Council of Scientific and Industrial Research
graduate studentship.
¶
To whom correspondence should be addressed: Dept. of
Microbiology and Cell Biology, Indian Inst. of Science, Bangalore 560 012, India. Tel.: 91-80-309-2686; Fax: 91-80-360-2697 or
91-80-360-0683; E-mail: varshney@mcbl.iisc.ernet.in.
Published, JBC Papers in Press, March 29, 2000, DOI 10.1074/jbc.M001238200
The abbreviations used are:
PTH, peptidyl-tRNA
hydrolase;
CAT, chloramphenicol acetyltransferase;
IF2, initiation
factor 2;
EFTu, elongation factor Tu;
GlnRS, glutaminyl-tRNA
synthetase;
MetRS, methionyl-tRNA synthetase.
The Fate of the Initiator tRNAs Is Sensitive to the Critical
Balance between Interacting Proteins*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
G) renders the tRNA (G72/U35A36) inactive in initiation because
it is defective in formylation. In this study, we isolated U1G72/U35A36
tRNA containing a wobble base pair at 1-72 positions as an intragenic
suppressor of the G72 mutation. The U1G72/U35A36 tRNA is
formylated and participates in initiation. More importantly, we show
that the mismatch at 1-72 positions of the initiator tRNA, which was
thus far thought to be the hallmark of the resistance of this tRNA
against peptidyl-tRNA hydrolase (PTH), is not sufficient. The amino
acid attached to the initiator tRNA is also important in conferring
protection against PTH. Further, we show that the relative levels of
PTH and IF2 influence the path adopted by the initiator tRNAs in
protein synthesis. These findings provide an important clue to
understand the dual function of the single tRNAMet in
initiation and elongation, in the mitochondria of various organisms.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
T) corresponding to position 1 of mature tRNA in the G72/U35A36 tRNA
gene rescues its defect in initiation. In vivo studies on the state of tRNAfMet, tRNAfMet (U35A36), and
their U1-G72 derivatives show that, in addition to the 1-72 pair, the
amino acid attached to the tRNA also plays an important role in its
recognition by PTH. Further, we have studied the influence of PTH and
IF2 overproduction on the path followed by the initiators in different
steps during protein synthesis.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Description of E. coli strains and plasmids used in this study
T) in the tRNA gene resulting in the isolation of U1G72/U35A36
as an intragenic suppressor of G72/U35A36 tRNA.
-lactamase, chloramphenicol acetyltransferase (CAT), and
-galactosidase activities using PADAC
(7-(thienyl-2-acetamido)-3,2-(4-N,N,dimethylaminophenyl-azo) pyridinium methyl-3-cephem-4 carboxylic acid),
14C-chloramphenicol, and
orthonitrophenyl-
-D-galactoside, respectively, as
substrates (17). The
-lactamase activities were determined for 5 µg of cell-free extract (17) and used to correct for the possible
copy number variation of the plasmid harboring the tRNA and the
CATam1 reporter. CAT assays were carried out by using 0.2-1.0 µg of cell-free extract. Percent chloramphenicol converted to acetyl chloramphenicol (1-acetyl and 3-acetyl chloramphenicol) was
then extrapolated to calculate chloramphenicol conversion/µg of
cell-free extract and normalized with respect to the corresponding
-lactamase activity. The initiation activity of tRNAfMet
(U35A36) was set as 100%, and all other activities were shown relative
to this activity. The
-galactosidase activities were determined in
Miller units (17, 24) using 30 µg of cell-free extracts and then
normalized with respect to the
-lactamase activity. The assays were
done at least twice, and the values did not vary by more than 10%. The
average values are shown in Tables III and IV. For the experiments
requiring overexpression of plasmid borne infB (IF2) or the
chromosomal lacZ (
-galactosidase), log phase cultures
were induced with 1 mM
isopropyl-1-thio-
-D-galactopyranoside for 4 h (21,
25).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (21K):
[in a new window]
Fig. 1.
A, the binary plasmids used in the assay
system. The pCATam1metYCUA harbors
the tRNAfMet and the reporter CATam1 genes. The
pACQS harbors the E. coli GlnRS gene. B, clover
leaf structure of the E. coli initiator
tRNA2fMet indicating the sites of
mutations.
T) in the G72/U35A36 tRNA gene. The mutation corresponded
to position 1 of the mature tRNA and resulted in the replacement of the
C1-G72 base pair with the U1-G72 wobble base pair (Fig. 1B).
DNA sequence analysis of the translation initiation region of the
CATam1 gene did not reveal any new mutations.
-lactamase activities). Compared with the U35A36 tRNA
(100%), the U1G72/U35A36 tRNA was ~56% active in initiation (Table
III).

View larger version (39K):
[in a new window]
Fig. 2.
Northern blot analysis of the steady state
levels of the mutant tRNAs isolated from E. coli CA274
in the presence of overproduced GlnRS. The blot was hybridized
simultaneously with 5'-32P-labeled oligonucleotides
complementary to E. coli
tRNA2fMet carrying the U35A36
mutation and E. coli tRNATyr.
Efficiency of aminoacylation of tRNAs by GlnRS

View larger version (24K):
[in a new window]
Fig. 3.
Northern blot analysis of total tRNAs
isolated under acidic conditions from E. coli CP78
(pth+) and AA7852
(pthts) grown at 30 °C or 37 °C, in
the presence (+) or absence (
) of GlnRS overproduction. The
initiator tRNAs were detected by use of the 5'-32P-labeled
oligonucleotide complementary to tRNAfMet (U35A36).

View larger version (46K):
[in a new window]
Fig. 4.
Northern blot analysis of tRNAs
isolated from E. coli CA274 harboring U1G72/U35A36
(A) or U35A36 (B) tRNA mutants in the
presence (+) or absence (
) of overproduction of PTH. The tRNAs
were isolated under acidic conditions and resolved on acid urea
gels. A mixture of 5'-32P-labeled oligonucleotides
complementary to tRNAfMet (U35A36) and tRNATyr
were used to detect the corresponding tRNAs. B, the
tRNAs were treated with either alkali (lane 1) or
CuSO4 (lane 2) to generate markers for uncharged
and formylated tRNAs, respectively.

View larger version (25K):
[in a new window]
Fig. 5.
Analysis of steady state levels of
tRNAfMet and tRNAfMet (U1G72) (CAU anticodon)
isolated from the E. coli B105 strain in the presence
(+) or absence (
) of PTH overproduction and with (+) or without (
)
overproduction of MetRS. The tRNAs were isolated under acidic
conditions, separated on acid urea gels, and probed with a
5'-32P-labeled oligonucleotide complementary to the
variable loop of the tRNA2fMet.
Effect of PTII and IF2 overproduction on initiation activities of
U35A36 and U1G72/U35A36 tRNAs

View larger version (49K):
[in a new window]
Fig. 6.
Northern blot analysis of the steady state
levels of tRNAs in the presence of IF2 and/or PTH overproduction.
The IF2 overexpression was induced by the addition of 1 mM
isopropyl-1-thio-
-D-galactopyranoside to the log phase
cultures for 4 h. The tRNAs were isolated under acidic conditions,
resolved by acid urea gels, and hybridized with
5'-32P-labeled oligonucleotides complementary to
tRNAfMet (U35A36).
-galactosidase thus produced provides a
measure of their elongation activities (33). As shown in Table
IV, the U35A36 tRNA (carrying the CxA
mismatch at the 1-72 positions) showed a basal level of
-galactosidase activity (77.7 units). Upon PTH overproduction, this
activity increased to 511.9 units. Similarly, although the U1G72/U35A36
tRNA served as a better elongator (1517.1 units), its activity in
elongation increased further when PTH was overproduced (3413.8 units).
Interestingly, when IF2 was simultaneously overproduced, these
elongation activities decreased to 70.1, 113.7, 213.1, and 774.7 (Table
IV).
Effect of PTH and IF2 overproduction on elongation activities of U35A36
and U1G72/U35A36 tRNAs
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-amino group of the amino acid attached to the
initiator tRNA may also contribute to its recognition by PTH. However,
considering that the physiological role of PTH demands nonselectivity
toward its substrate, these effects may be subtle for the tRNAs
attached to larger size peptides.

View larger version (20K):
[in a new window]
Fig. 7.
Schematic diagram showing different paths
adopted by the initiator tRNA.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Supported by a Dr. K. S. Krishnan fellowship.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Kozak, M.
(1983)
Microbiol. Rev.
47,
1-45
2.
Gualerzi, C.,
and Pon, C. L.
(1990)
Biochemistry
29,
5881-5889
3.
Guillon, J.-M.,
Heiss, S.,
Soutourina, J.,
Mechulam, Y.,
Laalami, S.,
Grunberg-Monago, M.,
and Blanquet, S.
(1996)
J. Biol. Chem.
271,
22321-22325
4.
Wu, X. Q.,
and RajBhandary, U. L.
(1997)
J. Biol. Chem.
272,
1891-1895
5.
Guillon, J.-M.,
Mechulam, Y.,
Blanquet, S.,
and Fayat, G.
(1993)
J. Bacteriol.
175,
4507-4514
6.
Varshney, U.,
Lee, C. P.,
and RajBhandary, U. L.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
2305-2309
7.
RajBhandary, U. L.
(1994)
J. Bacteriol.
176,
547-552
8.
Lee, C. P.,
and RajBhandary, U. L.
(1991)
J. Biol. Chem.
266,
18012-18017
9.
Guillon, J.-M.,
Meinnel, T.,
Mechulam, Y.,
Lazennec, C.,
Blanquet, S.,
and Fayat, G.
(1992)
J. Mol. Biol.
224,
359-367
10.
Lee, C. P.,
Seong, B. L.,
and RajBhandary, U. L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
9262-9266
11.
Lee, C. P.,
Mandal, N.,
Dyson, M. R.,
and RajBhandary, U. L.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7149-7152
12.
Schulman, L. H.,
and Pelka, H.
(1975)
J. Biol. Chem.
250,
542-547
13.
Kossel, H.,
and RajBhandary, U. L.
(1968)
J. Mol. Biol.
35,
539-560
14.
Atherly, A. G.,
and Menninger, J. R.
(1972)
Nat. New Biol.
240,
245-246
15.
Schulman, L. H.,
and Pelka, H.
(1985)
Biochemistry
24,
7309-7314
16.
Varshney, U.,
and RajBhandary, U. L.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
1586-1590
17.
Varshney, U,
Lee, C. P.,
Seong, B. L.,
and RajBhandary, U. L.
(1991)
J. Biol. Chem.
266,
18018-18024
18.
Brenner, S.,
and Beckwith, J. R.
(1965)
J. Mol. Biol.
13,
629-637
19.
Mandal, N.,
and RajBhandary, U. L.
(1992)
J. Bacteriol.
174,
7827-7830
20.
Garcia-Villegas, M. R.,
De La Vega, F. M.,
Galindo, F. M.,
Segura, M.,
Buckingham, R. H.,
and Guarneros, G.
(1991)
EMBO J.
10,
3549-3555
21.
Mangroo, D.,
and RajBhandary, U. L.
(1995)
J. Biol. Chem.
270,
12203-12209
22.
Varshney, U.,
and RajBhandary, U. L.
(1992)
J. Bacteriol.
174,
7819-7826
23.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Edition
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
24.
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
25.
Seong, B. L.,
Lee, C. P.,
and RajBhandary, U. L.
(1989)
J. Biol. Chem.
264,
6504-6508
26.
Varshney, U.,
Lee, C. P.,
and RajBhandary, U. L.
(1991)
J. Biol. Chem.
266,
24712-24718
27.
Sarin, P. S.,
and Zamecnik, P. C.
(1964)
Biochim. Biophys. Acta
91,
653-655
28.
Schofield, P.,
and Zamecnik, P. C.
(1968)
Biochim. Biophys. Acta
155,
410-416
29.
Perona, J. J.,
Swanson, R.,
Steitz, T. A.,
and Soll, D.
(1988)
J. Mol. Biol.
202,
121-126
30.
Seong, B. L.,
and RajBhandary, U. L.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
334-339
31.
Rould, M. A.,
Perona, J. J.,
Soll, D.,
and Steitz, T. A.
(1989)
Science
246,
1135-1142
32.
Dube, S. K.,
and Marcker, K. A.
(1969)
Eur. J. Biochem.
8,
256-262
33.
Seong, B. L.,
and RajBhandary, U. L.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
8859-8863
34.
Schmitt, E.,
Mechulam, Y.,
Fromant, M.,
Plateau, P.,
and Blanquet, S.
(1997)
EMBO J.
16,
4760-4769
35.
Dutka, S.,
Meinnel, T.,
Lazennec, C.,
Mechulam, Y.,
and Blanquet, S.
(1993)
Nucleic Acids Res.
21,
4025-4030
36.
Sprinzl, M.,
Horn, C.,
Brown, M.,
Ioudovitch, A.,
and Steinberg, S.
(1998)
Nucleic Acids Res.
26,
148-153
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Das and U. Varshney Peptidyl-tRNA hydrolase and its critical role in protein biosynthesis. Microbiology, August 1, 2006; 152(Pt 8): 2191 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Das, T. K. Dineshkumar, S. Thanedar, and U. Varshney Acquisition of a stable mutation in metY allows efficient initiation from an amber codon in Escherichia coli Microbiology, June 1, 2005; 151(6): 1741 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Laursen, H. P. Sorensen, K. K. Mortensen, and H. U. Sperling-Petersen Initiation of Protein Synthesis in Bacteria Microbiol. Mol. Biol. Rev., March 1, 2005; 69(1): 101 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stortchevoi, U. Varshney, and U. L. RajBhandary Common Location of Determinants in Initiator Transfer RNAs for Initiator-Elongator Discrimination in Bacteria and in Eukaryotes J. Biol. Chem., May 9, 2003; 278(20): 17672 - 17679. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Dineshkumar, S. Thanedar, C. Subbulakshmi, and U. Varshney An unexpected absence of queuosine modification in the tRNAs of an Escherichia coli B strain Microbiology, December 1, 2002; 148(12): 3779 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thanedar, T. K. Dineshkumar, and U. Varshney The Mere Lack of rT Modification in Initiator tRNA Does Not Facilitate Formylation-Independent Initiation in Escherichia coli J. Bacteriol., December 15, 2001; 183(24): 7397 - 7402. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |